VU rejoins ILCA as a core partner

June 28, 2021

The Chemistry and Pharmaceutical sciences group at Vrije Universiteit Amsterdam (VU) has recently rejoined Innovation Lab Chemistry (ILCA), which provides innovation support to chemical companies, supported by various organisations in the region. With this participation, the VU hopes to contribute new knowledge and expertise in addition to the existing universities that are already part of the Innovation Lab.

At ILCA it is seen as good news: “We are very pleased that VU adds their Pharmaceutical chemistry knowledge to the portfolio of expertise of ILCA. This means that companies and organizations in the MRA can benefit from a broader range of services to support their innovations and operational challenges”, says Willem Fokkema, director at ILCA.

The participation of VU will be coordinated by IXA-VU. “We make sure that questions from companies arrive on the right place” adds Ties van Rappard, business developer at VU. “We have extensive pharmaceutical expertise and (analytical) infrastructure in the labs of Prof Tom Grossmann useful for Lifesciences startup companies but also for mature companies in need for specific instruments. Regardless the question; analysis or synthesis. We find solutions”.

More news

Funding from KWF for palliative cancer patients in meaning-making at home

The diagnosis of incurable cancer profoundly disrupts patients’ lives, often causing existential crises and a sense of lost purpose. The KWF-funded project “In Search of Stories” (ISOS) aimed to support these patients by partnering them with spiritual counsellors and professional artists. This co-creation process proved highly beneficial. New funding from KWF Dutch Cancer Society supports […]

News

Impact in education and beyond: VU researcher Laura Rupp secures Comenius Leadership Fellow grant

Laura Rupp has been awarded the Comenius Leadership Fellow grant for a three-year period. This grant of 500,000 Euros, will fund a project titled “Global English and International Dutch on the VU Campus”. Over the years, Rupp has successfully reached more than 100,000 people online worldwide, teaching how to understand diverse English accents and speak […]

News

Max Nieuwdorp’s innovative research on gut microbes: a path to combat fatty liver disease

Internist Max Nieuwdorp, of Amsterdam UMC, discovered a few years ago that the microorganisms in the intestines of many overweight people produce alcohol to an increased extent. Breaking down excessive alcohol leads to fatty liver disease, which in turn poses a risk of serious conditions such as diabetes and cardiovascular disease. Nieuwdorp has now received an ERC Advanced Grant of 2.5 million euros for a major study into the underlying causes of this excessive alcohol production.  

News
All news